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Summary  
Three-dimensional (3-D) cell cultures hold enormous potential to advance our 
understanding of infectious disease and to effectively translate basic cellular 
research into clinical applications. Using novel NASA bioreactor technology, the 
rotating wall vessel (RWV), we have engineered physiologically relevant 3-D 
human tissue culture models for infectious disease studies. The design of the 
RWV is based on the understanding that organs and tissues function in a 3-D 
environment, and that this 3-D architecture is critical for the differentiated form 
and function of tissues in vivo. The RWV provides large numbers of cells which 
are amenable to a wide variety of experimental manipulations and provides an 
easy, reproducible, and cost-effective approach to enhance differentiated 
features of cell culture models. 
 
Introduction  
The more representative the phenotype of the tissue culture model to the 
parental tissue, the greater will be the relevance of the model to the infection 
process in vivo. Thus, a more complete understanding of the mechanisms of 
human infectious disease will depend upon the development of physiologically 
relevant models of human cell cultures that can be used to identify and 
characterize host and microbial products important for infection. Such models 
also have exciting potential for the discovery/development of novel therapeutics. 
 
Much of our knowledge of how microbial pathogens cause infection is from 
studying experimental infections of standard monolayers grown as flat two-
dimensional (2-D) cultures on impermeable surfaces of plastic or glass. While 
these models continue to contribute to our understanding of infectious diseases, 
they are greatly limited in the extent to which they model the complexity of an 
intact 3-D tissue. In particular, this method of culture prevents the cells from 
establishing the 3-D architecture that is critical for the differentiated structure and 
function of parental tissues in vivo [5, 7-9] and from responding to chemical and 
molecular gradients in three-dimensions (at apical, basal, and lateral cell 
surfaces) [9].  
 
There are a variety of methods that have been used to enhance the 
differentiation of cultured cells, including permeable inserts, transplanted human 
cells grown as xenografts in animals, and explanted human biopsies. These 
models have provided important insights into microbial pathogenesis, despite 
limitations such as short lifetimes, laborious set-up, experimental variability, 
availability and limited numbers of cells.  
 
Use of the RWV bioreactor to engineer biologically meaningful 3-D cell 
cultures 
 
Optimally, cell culture model design should mimic both the 3-D organization and 
differentiated function of an organ, while allowing for experimental analysis in a 
high throughput platform.  
 
Originally designed by NASA engineers, the RWV is an optimized suspension 
culture technology for growing 3-D cells that maintain many of the specialized 
features of in vivo tissues [6, 10]. The RWV bioreactor is based on a rotating 
cylinder completely filled with culture medium, in which the sedimentation of cells 
within the vessel is offset by the rotating fluid, creating a constant fall of cells 
through the culture medium [Figure 1]. Oxygen is provided to cells through a 
hydrophobic membrane at the back of the bioreactor. These conditions maintain 
cells in suspension under levels of low, physiologically relevant shear, enabling 
them to attach to one another, differentiate, and form the fragile connections that 
are required for complex tissue-like 3-D structures [2, 6, 10] [Figure 2].  
 
Applying 3-D cell cultures to study infectious disease 
 
Cell culture in the RWV is easy to perform. Cells are first grown as monolayers in 
tissue culture flasks. At the appropriate density, cells are removed from the flask, 
resuspended in medium, and incubated with porous collagen-coated microcarrier 
beads for attachment [Figure 1]. The cell-bead complexes are then introduced 
into the RWV and rotation is initiated. 3-D cells cultured on the surface of porous 
microcarrier beads are able to sense and respond to chemical and molecular 
gradients like the parental tissue in vivo. The medium is changed as necessary 
and vessel rotation speed is increased as cultures grow to maintain cells in 
suspension. The 3-D cells are then removed from the bioreactor and distributed 
evenly in multi-well plates or other convenient formats for testing. 3-D cells are 
amenable to a wide range of experimental manipulations, and can be removed 
from the bead with various treatments for use in studies that require 
homogeneous cell suspensions, like flow cytometry. 
 
Publications from our team have shown that a variety of different 3-D cultures, 
including human intestine, lung, and placental models, more closely resemble the 
physiology of their parental tissues in vivo as compared to the same cells grown 
as monolayers, and respond to infection with microbial pathogens in ways that 
reflect the natural infection process [1-4]. We reported the first use of 3-D cell 
culture models of human intestinal epithelium generated in the RWV to study the 
enteric pathogen Salmonella typhimurium [1]. Compared to monolayers, 3-D 
culture of human intestinal cell lines enhanced many characteristics associated 
with fully differentiated functional intestinal epithelia in vivo, including distinct 
apical and basolateral polarity, increased expression and better organization of 
tight junction, extracellular matrix, and brush border proteins, and highly localized 
expression of mucins. All of these important physiological features of in vivo 
intestinal epithelium were either absent or not expressed or distributed at 
physiologically relevant levels in monolayer cultures. When applied to study 
aspects of human enteric salmonellosis, our 3-D intestinal cultures responded in 
ways that were similar to an in vivo infection, including differences in tissue 
pathology, adherence, invasion, apoptosis, and cytokine expression. Our current 
studies with these models include a) evaluation of known pathogenesis 
determinants of Salmonella, b) evaluation of other enteric pathogens, and c) 
introduction of biological signals that mimic what such tissues encounter in vivo, 
as part of a broader effort to understand particular interactions between 
pathogens and the host intestinal epithelium. 
 
Recently, we described the establishment/characterization of a 3-D model of 
human lung epithelium and its application to study the pathogenesis of 
Pseudomonas aeruginosa [3]. As with our 3-D intestinal models, cultivation of a 
human lung cell line in the RWV resulted in the formation of 3-D tissue 
aggregates that displayed important structural and functional characteristics of 
the differentiated parental tissue, including enhanced and extensive formation of 
tight junctions, extracellular matrix proteins, and mucus production [Figure 3]. 
These features were not observed in monolayers of the same cells. In response 
to infection with P. aeruginosa, the 3-D lung cells, but not monolayers, responded 
in ways that were relevant to the infection in vivo, including differences in 
bacterial colonization, cellular morphology, and cytokine expression profiles. 
Collectively, these studies show that the use of the RWV to generate 3-D 
cultures from a variety of cell types has wide applications in the modeling of 
infectious disease.  
 
3-D cell culture has wide applications for infectious disease studies and 
drug development 
 
3-D cell cultures provide alternative organotypic models that will complement 
existing experimental systems to study human infectious disease, and are a 
powerful tool for the commercial development of novel therapeutics. Accordingly, 
we along with our collaborators, have generated a variety of 3-D cell cultures 
from different human tissues that model many aspects of their in vivo parental 
tissues, and which are currently being used in infection studies. These 3-D cell 
cultures include models of colon, lung, placenta, bladder, and periodontal 
ligament. Beyond our infectious disease applications, 3-D cell cultures have been 
used in a variety of other biomedical applications including studying immune-cell 
interactions, growing tissues for transplantation, cancer biology, stem cell 
research, and developing/testing of novel therapeutics 
[http://www.synthecon.com]. 
 
These 3-D models are simple, high-throughput systems that create very large 
numbers of cells per experiment, and can be studied by techniques not possible 
or limited in many other advanced in vitro models. The high fidelity, 
reproducibility, and cost-efficiency of 3-D cell culture offers a powerful screening 
tool for therapeutics and holds tremendous potential for drug and target 
validation/discovery. 3-D cell-based models have been effectively used to re-
examine molecular pathways previously characterized by conventional culture 
methodologies as well as to elucidate novel signaling pathways during normal 
cellular differentiation and tumor progression [7]. By analogy, 3-D cell culture 
holds enormous potential for novel product development for the diagnosis, 
prevention, and treatment of infectious disease.  
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Figure 1: (A) Operation of the RWV. The vessel is filled with growth medium 
and cells are added.  Vessel rotation is initiated. (B) Cells cultured in the RWV 
are maintained in a gentle fluid orbit. (C) Depiction of a collagen-coated 
microcarrier bead to which cells have attached on the surface. Reprinted with 
permission from ASM. 
 
Figure 2: Confocal image of 3-D Int-407 cells following infection with S. 
typhimurium. Phalloidin labeling of the actin cytoskeleton of 3-D Int-407 cells 
(red) after infection with GFP-labeled S. typhimurium (green). Reprinted with 
permission from ASM. 
 
Figure 3: Immunostaining of 3-D A549 cells. 3-D A549 cells (A,C,E,G) and 
A549 monolayers (B,D,F,H) stained with antibodies against tight junctional 
markers: ZO-1 (A,B); Occludin (C,D); E-Cadherin (E,F) and β-Catenin (G,H).  3-D 
cells showed higher levels of staining with distinct localization to cell-cell 
interfaces, while monolayers had diffuse staining patterns. Reprinted with 
permission from ASM. 
 
 
 
 
 
 
 
 
 



